LGND - Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q1 2022 Results - Earnings Call Transcript

Ligand Pharmaceuticals Incorporated (LGND) Q1 2022 Earnings Conference Call May 04, 2022 04:30 PM ET Company Participants Simon Latimer - Head of Investor Relations John Higgins - CEO Matt Foehr - COO Matt Korenberg - CFO Conference Call Participants Larry Solow - CJS Securities Matt Hewitt - Craig Hallum Capital Presentation Operator Good day, everyone. And welcome to the Ligand Pharmaceuticals First Quarter '22 Earnings Call. At this time, all participants are in a listen-only mode [Operator Instructions]. Please note this call maybe recorded. It is now my pleasure to turn today's program over to Simon Latimer, Head of Investor Relations. Please go ahead. Simon Latimer Thanks. Welcome to Ligand's first quarter of 2022 financial results and business update conference call. Our speakers for today's call are in separate locations. Speaking today for Ligand will be John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO. We will use non-GAAP

For further details see:

Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q1 2022 Results - Earnings Call Transcript